Currently, there are 5.84M common shares owned by the public and among those 5.22M shares have been available to trade.
The company’s stock has a 5-day price change of 32.77% and 9.78% over the past three months. CHEK shares are trading 18.75% year to date (YTD), with the 12-month market performance up to 87.12% higher. It has a 12-month low price of $1.25 and touched a high of $4.62 over the same period. CHEK has an average intraday trading volume of 25.75K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 23.21%, 17.52%, and -12.72% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Check-Cap Ltd (NASDAQ: CHEK) shares accounts for 1.07% of the company’s 5.84M shares outstanding.
It has a market capitalization of $14.45M and a beta (3y monthly) value of 0.06. Price movements for the stock have been influenced by the stock’s volatility, which stands at 10.95% over the week and 7.43% over the month.
Analysts forecast that Check-Cap Ltd (CHEK) will achieve an EPS of -$0.87 for the current quarter, $0 for the next quarter and -$2.59 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.87 while analysts give the company a high EPS estimate of -$0.87. Comparatively, EPS for the current quarter was -$0.63 a year ago. Earnings per share for the fiscal year are expected to increase by 4.45%, and 22.05% over the next financial year.
H.C. Wainwright coverage for the Check-Cap Ltd (CHEK) stock in a research note released on January 11, 2018 offered a Buy rating with a price target of $6. H.C. Wainwright was of a view on November 28, 2017 that the stock is Buy, while H.C. Wainwright gave the stock Buy rating on September 28, 2017, issuing a price target of $6- $7. Rodman & Renshaw on their part issued Buy rating on January 19, 2017.
